Coronary Artery Disease Market Forecast 2025-2034: Growth Dynamics, Emerging Trends, and Strategic Opportunities
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What External and Internal Drivers Are Contributing to the Growth of theCoronary Artery Disease Market?
The anticipated surge in coronary artery disease incidences is likely to fuel the expansion of the market for this particular disease in the forthcoming years. Coronary artery disease (CAD), a physiological disorder denoted by the constriction or obstruction of coronary arteries that are key blood suppliers to the heart’s muscles, is seeing ascendency due to heightened alterations in dietary habits, added stress, lack of physical exercise, obesity, aging, etc. Disease management for coronary artery disease is achieved through medicinal application of drugs like clopidogrel, ticagrelor, warfarin, and heparin and procedures comprising coronary artery bypass grafting, angioplasty, and stenting. For example, as stated by the Centre of Disease Control and Prevention, a federal agency affiliated to U.S Department of Health and Human Services in May 2024, coronary heart disease (CHD) was identified as the primary form of heart disease, responsible for 371,506 fatalities in 2022. Nearly 5% of adults aged 20 or more (or 1 in 20) were diagnosed with coronary artery disease (CAD). In 2022, approximately 1 in 5 deaths due to cardiovascular disease (CVD) were found in adults under the age of 65. Hence, the escalating prevalence of coronary artery disease is predicted to spur on the growth of the coronary artery disease market throughout the estimation period.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12052&type=smp
#What is the Projected CAGR for the Coronary Artery Disease Market Size from 2025 to 2034?
In recent times, there has been a solid expansion in the coronary artery disease market. The size of this market is set to rise from $29.15 billion in the year 2024 to $31.97 billion in the following year, 2025, experiencing a compound annual growth rate (CAGR) of 9.7%. This significant growth observed in the past years is due to several factors such as the widespread incidence of coronary artery disease, the escalation in the practice of minimally invasive surgeries, a rise in sedentary lifestyles, an aging population with prevalent coronary artery disease, and the advancement in pharmacological treatments.
The market size for coronary artery disease is predicted to undergo substantial expansion in the forthcoming years, reaching a size of $48.48 billion in 2029 with a compound annual growth rate (CAGR) of 11.0%. This growth observed in the forecast period can be linked to factors such as increasing lifestyle-related issues, emphasis on telemedicine and remote monitoring, broadening the scope of interventional cardiology procedures, shift towards value-focused health care models, and the advent of new drug therapies. Significant trends during the projected period involve the emergence of gene therapies, the introduction of artificial intelligence in diagnosis, deeper attention to mental health within CAD care, the rise of home-care health services and the implementation of remote cardiac rehabilitation.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12052
Which Upcoming Market Trends and Innovations Are Set to Influence theCoronary Artery Disease Market’s Path Forward?
Leading firms in the coronary artery disease market are prioritizing the development of innovative technologies like AI-based blood tests in order to maintain their competitive vantage. This AI-enabled blood test employs AI algorithms to analyze and interpret data related to blood. For example, in February 2023, Cardio Diagnostics Holdings, an American firm specializing in AI-integrated genetic-epigenetic engine production, proclaimed the introduction of PrecisionCHD. This is a sophisticated combined genetic and epigenetic blood examination targeted at early diagnosis of coronary heart disease. With an accuracy of over 75% in identifying coronary heart disease among both genders, PrecisionCHD utilizes a machine-learning model. This model sifts through billions of genomic and epigenomic data points and incorporates epigenetic (DNA methylation) and genetic (single nucleotide polymorphism) biomarkers into the test.
Who Are the Dominant Market Players Pushing the Boundaries of theCoronary Artery Disease Market?
Major companies operating in the coronary artery disease market include Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Gilead Sciences Inc., Amgen Inc. , Viatris Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A., Lupin Pharmaceuticals Inc., Wockhardt Ltd., Honya Medical Inc., Idorsia Pharmaceuticals Ltd., Cytokinetics Inc., Kowa Pharmaceuticals America Inc., Sinotau Pharmaceutical Group, HRV Global Life Sciences, Barr Pharmaceuticals Inc., AdvanceCor GmbH, Deutsches Zentrum für Herz- Kreislauf-Forschung (DZHK) e.V.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report
#thebusinessresearchcompany #marketresearch #marketintelligence
The coronary artery disease market covered in this report is segmented –
1) By Treatment: Medication, Surgery, Additional Therapy, Other Treatments
2) By Diagnosis: Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterization, Heart CT Scan, Other Diagnosis
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Channels
4) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Medication: Antiplatelet Agents, Beta-Blockers, Statins, ACE Inhibitors, Other Medications
2) By Surgery: Coronary Artery Bypass Grafting, Angioplasty And Stenting, Heart Valve Surgery, Other Surgical Interventions
3) By Additional Therapy: Cardiac Rehabilitation, Lifestyle Modification Programs, Alternative Therapies
4) By Other Treatments: Gene Therapy, Stem Cell Therapy, Innovative Devices
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12052&type=smp
What Regions Are Dominating the Coronary Artery Disease Market Growth?
North America was the largest region in the coronary artery disease market in 2024. The regions covered in the coronary artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Gobal Coronary Artery Disease Maret 2025, By The Business Research Company:
Automotive Repair and Maintenance Global Market Report 2024
Electric Motor And Generator Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/electric-motor-and-generator-global-market-report
Automotive Cables Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/automotive-cables-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
